Search

Researchers at MSK published updated data today in the New England Journal of Medicine from the ongoing, single-arm Phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping alterations.

… Friday, May 29, 2020 Researchers at Memorial Sloan Kettering Cancer Center (MSK) published updated data today in the New England Journal of Medicine from the ongoing, single-arm phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with

Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.

… Tuesday, January 11, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of the Fiona and Stanley Druckenmiller Presidential Innovation Fund. The new initiative, made possible by a transformative $100 million gift from the Fiona and Stanley Druckenmiller Foundation, is expected

Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, presented results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.

… Sunday, June 4, 2023 New data led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Dana-Farber Brigham Cancer Center featured in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting press program and simultaneously published in  The New England Journal of Medicine (NEJM

… Thursday, April 3, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Almudena Chaves Perez, Adriana Mujal, Hina Shah, and Lydia Paraskevi Tsamouri Awarded the 2025 Kravis WiSE Fellowships Almudena Chaves Perez, Adriana Mujal, Hina Shah, and Lydia

Discover where three recent Gerstner Sloan Kettering graduates are now and learn about the research they’re pursuing.

… Tuesday, September 20, 2016 Gerstner Sloan Kettering graduate James Mahaffey works in a lab at the Perlmutter Cancer Center at NYU School of Medicine exploring the RAS gene, which is mutated in nearly a third of cancers but has resisted targeting with drugs. James Mahaffey studies RAS, a gene that is

Memorial Sloan Kettering’s suburban presence is expanding with its newest and largest state-of-the-art facility set to welcome patients on October 6 in West Harrison, New York.

… Wednesday, October 1, 2014 VIDEO | 04:30 Virtual Tour of Memorial Sloan Kettering Cancer Center Westchester Take a virtual tour of our suburban outpatient location and hear from our doctors on the benefits of receiving care at MSK Westchester. Video Details Memorial Sloan Kettering’s suburban presence

Experiments with zebrafish and human pluripotent stem cells reveal the necessary ingredients, besides genetic mutations, that fuel the development of melanoma.

… Friday, September 3, 2021 Right now, in your body, lurk thousands of cells with DNA mistakes that could cause cancer. Yet only in rare instances do these DNA mistakes, called genetic mutations, lead to a full-blown cancer. Why? The standard explanation is that it takes a certain number of genetic “hits

… Tuesday, December 2, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Omar Abdel-Wahab Elected to the National Academy of Medicine (NAM) Omar Abdel-Wahab Omar Abdel-Wahab, MD , Chair of the Molecular Pharmacology Program at Sloan Kettering Institute

Justin Perry, PhD, cell biologist and immunologist of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named a recipient of the 2021 National Institutes of Health (NIH) Director’s New Innovator Award.

… Tuesday, October 5, 2021 Justin Perry, PhD , cell biologist and immunologist of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 64 recipients of the prestigious 2021 National Institutes of Health (NIH) Director’s New Innovator Award . As part of the award, Dr. Perry

Practical tips for caregivers helping an older relative or friend make decisions about cancer treatment.

… Friday, November 25, 2016 Summary An older adult who is diagnosed with cancer may need help making treatment decisions. Our Geriatrics Service Chief discusses how to lend support. Highlights Decisions should be made based on each individual’s unique situation. It’s important to consider the goals of